| Financial Year |
March 31 2023 |
| Monetary Funds |
426,284,779.24 |
| Held-for-trading Financial Assets |
187,964,085.93 |
| Notes Receivable |
13,098,535.85 |
| Accounts Receivable |
177,173,379.84 |
| Advances to Suppliers |
14,907,599.48 |
| Other Receivables |
3,721,685.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
104,148,195.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,086,513.63 |
| Total Current Assets |
946,923,536.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,749,663.53 |
| Investment Properties |
29,267,540.09 |
| Fixed Assetes |
285,234,384.76 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,634,475.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,965,177.30 |
| Deferred Income Tax Assets |
3,507,221.86 |
| Other Non-Current Assets |
132,568.00 |
| Sub-Total of Non-Current Assets |
423,517,959.87 |
| Total Assets |
1,370,441,496.12 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
43,461,018.65 |
| Accounts Received In Advance |
78,892.56 |
| Employee Compensation Payable |
8,561,475.92 |
| Taxes Payable |
4,128,996.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,325,358.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,707,246.10 |
| Other Current Liabilities |
3,809,621.99 |
| Sub-Total of Current Liabilities |
78,702,199.42 |
| Long-term Loans |
-- |
| Bonds Payable |
254,292,672.30 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,855,170.92 |
| Deferred Income Tax Liabilities |
1,480,625.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
276,269,609.31 |
| Total Liabilities |
354,971,808.73 |
| Paid-In Capital(Or Share Stock) |
185,187,838.00 |
| Capital Surplus |
458,861,508.90 |
| Surplus Reserve |
53,335,209.14 |
| LESS:Treasury Stock |
40,002,203.00 |
| Undistributed Profits |
282,400,636.38 |
| Minority Stockholder's Interest |
135,488.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,015,334,199.13 |
| Owner's Equity（Stockholder's Equity） |
1,015,469,687.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,370,441,496.12 |
